
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pacific 8 Ventures is a venture capital firm established to focus on technology companies that are transforming healthcare. Founded in the United States, the firm primarily invests at the seed stage, often acting as the first institutional investor in its portfolio companies. This strategic positioning allows Pacific 8 Ventures to provide essential early-stage support to startups aiming to innovate within the healthcare sector.
The firm has built a portfolio of 10 companies, showcasing its commitment to identifying and nurturing disruptive technologies in healthcare. Pacific 8 Ventures emphasizes the importance of being at the forefront of investment in the U.S. market, which it views as ripe for significant innovations in therapeutics, diagnostics, and health services. The firm’s approach combines financial backing with strategic support, enhancing the market access capabilities of its portfolio companies.
Pacific 8 Ventures invests in disruptive technology platforms that are transforming therapeutics, diagnostics, and broader health services. The firm primarily targets seed-stage investments within the U.S. market, which it identifies as having substantial potential for disruptive innovations. The investment strategy focuses on companies that leverage advanced technologies to address critical challenges in healthcare.
Investment checks typically range from $500,000 to $2 million, allowing Pacific 8 Ventures to be a significant early backer of its portfolio companies. The firm seeks founders who demonstrate a strong vision and capability to execute their ideas, particularly in sectors such as healthcare, biotech, and artificial intelligence. Pacific 8 Ventures is particularly interested in startups that can provide innovative solutions to improve patient outcomes and streamline healthcare processes.
Pacific 8 Ventures has a diverse portfolio of 10 companies, each contributing to the transformation of healthcare through innovative technologies. Notable portfolio companies include:
This portfolio reflects Pacific 8 Ventures' commitment to investing in companies that are at the forefront of healthcare innovation, particularly in the areas of AI, biotech, and healthcare services.
Ser-Chen, MD: Brings clinical experience and serves as faculty at Tzu-Chi University in Taiwan. His expertise lies in healthcare technology and clinical applications.
Jack: Has over 15 years of experience in healthcare technology, previously serving as Director at PerkinElmer and CambridgeSoft. His background includes significant contributions to technology transformations in the healthcare sector.
Chris: Possesses more than 15 years of experience in venture capital and technology transformations, having previously been a Partner at McKinsey & Company. His insights into market dynamics and investment strategies are invaluable to the firm.
To pitch Pacific 8 Ventures, founders should submit their proposals through the firm's website at pac8.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and technology's impact on healthcare. The firm prefers warm introductions but will consider direct submissions.
Response times may vary, but founders can generally expect feedback within a few weeks. Clear and concise communication is essential to capture the firm's interest.
Pacific 8 Ventures has been actively building its portfolio, with notable investments in companies such as Mammoth Biosciences and Certainly Health. These investments reflect the firm's commitment to supporting disruptive technologies in healthcare.
As of October 2023, the firm continues to seek out innovative startups that align with its investment thesis, focusing on transformative healthcare solutions that leverage technology.
What are Pacific 8 Ventures' investment criteria?
Pacific 8 Ventures focuses on seed-stage investments in technology companies that are transforming healthcare. The firm looks for disruptive innovations in therapeutics, diagnostics, and health services, primarily within the U.S. market.
How can I pitch to Pacific 8 Ventures?
Founders can pitch their startups through the Pacific 8 Ventures website at pac8.com. It is recommended to include a clear business model, market analysis, and details on how the technology addresses a significant healthcare challenge.
What makes Pacific 8 Ventures different from other investors?
Pacific 8 Ventures positions itself as a first institutional investor, providing not only capital but also strategic support to enhance market access for its portfolio companies. This dual approach helps startups navigate the complexities of the healthcare landscape.
What is the typical check size for investments?
Pacific 8 Ventures typically invests between $500,000 and $2 million in seed-stage companies, allowing them to play a significant role in the early development of their portfolio companies.
What sectors does Pacific 8 Ventures focus on?
The firm primarily invests in healthcare, biotech, and AI sectors, targeting companies that leverage technology to improve patient outcomes and healthcare delivery.
What kind of support can portfolio companies expect?
Pacific 8 Ventures provides strategic support in addition to financial backing, helping portfolio companies with market access and operational guidance to enhance their growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.